Jazz Pharmaceuticals plc — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2012-01-11

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-11	Common Stock	M	30000	$4.21	Acquired	30000	Direct
2012-01-11	Common Stock	F	2598	$48.60	Disposed	27402	Direct
2012-01-11	Common Stock	M	10000	$6.33	Acquired	37402	Direct
2012-01-11	Common Stock	F	1302	$48.60	Disposed	36100	Direct
2012-01-11	Common Stock	M	12500	$8.23	Acquired	48600	Direct
2012-01-11	Common Stock	F	2116	$48.60	Disposed	46484	Direct
2012-01-11	Common Stock	M	12500	$34.99	Acquired	58984	Direct
2012-01-11	Common Stock	F	8999	$48.60	Disposed	49985	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-11	Option (right to buy)	$4.21	M	30000	Disposed	2019-07-07	Common Stock (30000)	Direct
2012-01-11	Option (right to buy)	$6.33	M	10000	Disposed	2019-08-16	Common Stock (10000)	Direct
2012-01-11	Option (right to buy)	$8.23	M	12500	Disposed	2020-08-25	Common Stock (12500)	Direct
2012-01-11	Option (right to buy)	$34.99	M	12500	Disposed	2021-11-04	Common Stock (12500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2827390	Indirect
Common Stock	56667	Indirect

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price.

F2: The Reporting Person is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P., except to the extent of his pecuniary interest therein.

F3: This nonstatutory stock option has a vesting schedule of one third vested on July 7, 2010 and the remainder vesting in 24 equal monthly installments thereafter.

F4: This nonstatutory stock option vested in 12 equal monthly installments from August 17, 2009.

F5: This nonstatutory stock option vested in 12 equal monthly installments from August 15, 2010.

F6: This nonstatutory stock option has a vesting schedule of 100% vesting in 12 equal monthly installments from August 15, 2011.

F7: On October 24, 2011, the Board of Directors of the Issuer approved the full vesting of unvested nonstatutory stock options held by the Issuer's officers and non-employee directors, including the Reporting Person. Such vesting acceleration became effective on December 13, 2011.